Speaker illustration

Professor Pablo Avanzas Fernandez

Asturias Central University Hospital, Oviedo (Spain)

Member of:

European Society of Cardiology

Dr. Avanzas graduated in Medicine at Universidad de Navarra, in Spain. He completed registrar training in Cardiology at Gregorio Marañón Hospital and an European PhD in Complutense University, in Madrid. He was appointed Associate Research Investigator of the Cardiovascular Biology Research Centre at St. George´s Hospital in London. Dr. Avanzas is now senior Interventional Cardiologist in Hospital Universitario Central de Asturias, Oviedo, Spain. His research interest include: structural heart disease, particularly aortic stenosis and TAVI; coronary artery disease and cardiovascular pharmacotherapy. Associate Professor of Medicine, University of Oviedo, Spain. Secretary, Executive Committee, ISCP (International Society of Cardiovascular Pharmacotherapy) Executive Master in Healthcare Organization Leadership Program, Georgetown University and ESADE Business School. Associate Editor, International Journal of Cardiology and Revista Española de Cardiolo PUBMED: 328 entries.

High risk patients with coronary artery disease

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb